MHC Typing of Macaques Used in AIDS Research
MHC Typing of Macaques Used in AIDS Research
批准号:
8319674
负责人:
David I Watkins
金额:
$67.18万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-02-01 至 2014-07-31
关键词:
Acquired Immunodeficiency SyndromeAllelesAmericanAnimal ModelAnimalsBindingCell LineClinicalClinics and HospitalsCommunitiesCytotoxic T-LymphocytesDNAEpitopesEuropeanFundingGoalsHIVHIV vaccineHaplotypesHelper-Inducer T-LymphocyteHistocompatibilityHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumanImmunogeneticsIndividualInfectionLaboratoriesLearningMHC Class I GenesMHC Class II GenesMacacaMacaca mulattaManuscriptsMapsMolecularNetherlandsPathogenesisPeptidesPrimatesPublicationsRequest for ProposalsResearchResearch PersonnelSIVSamplingServicesSocietiesTechnologyTestingTrainingTransplantationUnited StatesUniversitiesVaccinatedVaccinesWisconsinWorkexperienceexperimental analysislymphoblastoid cell linenonhuman primateprogramspublic health relevanceresponsevaccine development
中文摘要
描述(申请人提供):我们计划继续为北美和欧洲科学界提供猕猴MHC分型的服务。这将包括对编码MHC I类和II类分子的等位基因进行PCR-SSP测试,这些分子结合来自SIV的多肽。此外,我们将继续为希望在自己的实验室建立MHC打字系统的个人提供培训。最后,我们将继续开发一组具有良好特性的细胞系,这对分析猕猴体内的MHC将是无价的。到目前为止,我们已经为大约50名研究人员使用了超过11.4万种测试,输入了超过1.5万只猕猴。这些排版支持出版了75份以上的手稿。因此,这项申请的两个具体目标是:1.为研究印度恒河猴的研究人员提供I类和II类基因座的MHC分型。扩展我们的猕猴I类和II类等位基因的分子分型菜单。
公共卫生相关性(由申请人提供):猕猴体内的SIV感染是研究艾滋病毒感染者的最佳动物模型。此外,接种疫苗的猕猴面临的SIV挑战对HIV疫苗的开发至关重要。了解猕猴的MHC分子是发病机制和疫苗研究的核心。
英文摘要
DESCRIPTION (provided by applicant): We plan to continue to offer services to both the North American and European scientific communities for MHC typing of macaques. This will include PCR-SSP tests for alleles encoding MHC class I and II molecules that bind peptides derived from SIV. Additionally, we will continue to offer training for individuals who wish to set up MHC typing in their own laboratories. Finally, we will continue to develop a panel of well-characterized cell lines that will be invaluable for the analysis of the MHC in the macaque. To date, we have typed more than 15,000 macaques for approximately 50 investigators using over 114,000 tests. These typings have supported the publication of over 75 manuscripts. The two specific aims of this application are, therefore, to: I. Offer MHC typing of the class I and II loci for investigators working with Indian rhesus macaques. II. Expand our menu for the molecular typing of the macaque's class I and II alleles.
PUBLIC HEALTH RELEVANCE (provided by applicant): SIV infection in macaques is the best animal model to study HIV-infected humans. Furthermore, SIV challenge of vaccinated macaques is critical to HIV vaccine development. Understanding the MHC molecules of the macaque is central to both pathogenesis and vaccine studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10422995
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10669613
-
项目类别:
-
资助金额:$97.87万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10463875
-
项目类别:
-
资助金额:$98.85万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
-
批准号:8787712
-
项目类别:
-
资助金额:$61.94万
-
财政年份:2014
-
负责人:David I Watkins
-
依托单位:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
-
批准号:8976140
-
项目类别:
-
资助金额:$53.0万
-
财政年份:2014
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8497605
-
项目类别:
-
资助金额:$214.55万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Protective Immunity
-
批准号:8307106
-
项目类别:
-
资助金额:$51.45万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8688135
-
项目类别:
-
资助金额:$194.7万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8301117
-
项目类别:
-
资助金额:$215.84万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8874851
-
项目类别:
-
资助金额:$195.69万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
DEVELOPMENT OF IMMUNE MONITORING REAGENTS AND MHC TYPING TECHNOLOGIES
-
批准号:8358206
-
项目类别:
-
资助金额:$63.15万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT
-
批准号:8358204
-
项目类别:
-
资助金额:$23.83万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
IMMUNOGENICITY AND PROTECTION OF LIVE ATTENUATED SIV239 DELTA NEF IN RHESUS
-
批准号:8358203
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
MINIGENE VACCINATION WITH EARLY PRESENTED VIRAL PROTEINSAIDS RELATED RESEARCH
-
批准号:8358214
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
SIV-specific Mamu-E-restricted CD8+ T cells
-
批准号:8071437
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
CRYPTIC ORFS AS A VACCINE FOR HIV
-
批准号:8358237
-
项目类别:
-
资助金额:$5.96万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
PROTECTIVE EFFICACY OF MERCK AD5 PRIME/BOOST AGAINST MUCOSAL CHALLENGE
-
批准号:8358247
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
VACCINE REGIMENS TO INDUCE CD4+ AND CD8+ T CELLS AGAINST SIV EPITOPES
-
批准号:8358223
-
项目类别:
-
资助金额:$9.53万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
SIV-specific Mamu-E-restricted CD8+ T cells
-
批准号:8212162
-
项目类别:
-
资助金额:$21.64万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
MHC TYPING OF MACAQUES USED IN AIDS RESEARCH
-
批准号:8358202
-
项目类别:
-
资助金额:$28.59万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
海外基金